The fact that Myc-induced B-lymphoma cells are sensitive to Chk1 inhibition is promising for lymphoma treatment, but recent data suggest that the sensitivity reflects a B-cell lineage sensitivity (30). The gene discussed is CHEK1; the disease is lymphoma.